These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Preclinical and early clinical experience with a biodegradable polymer-based, rapamycin-eluting, Indian drug-eluting coronary stent: the BIO-RAPID study. Bhargava B, Karthikeyan G, Shankar PB, Seth S, Singh S, Pr U, Lal AV, Mohanty M. Indian Heart J; 2008; 60(3):228-32. PubMed ID: 19240312 [Abstract] [Full Text] [Related]
23. Experimental efficacy of an everolimus eluting cobalt chromium stent. Carter AJ, Brodeur A, Collingwood R, Ross S, Gibson L, Wang CA, Haller S, Coleman L, Virmani R. Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598 [Abstract] [Full Text] [Related]
24. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Circulation; 2007 May 08; 115(18):2435-41. PubMed ID: 17438147 [Abstract] [Full Text] [Related]
25. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems. Young JJ. Rev Cardiovasc Med; 2007 May 08; 8 Suppl 1():S3-10. PubMed ID: 17401309 [Abstract] [Full Text] [Related]
29. Stent-induced neutrophil activation is associated with an oxidative burst in the inflammatory process, leading to neointimal thickening. Inoue T, Kato T, Hikichi Y, Hashimoto S, Hirase T, Morooka T, Imoto Y, Takeda Y, Sendo F, Node K. Thromb Haemost; 2006 Jan 08; 95(1):43-8. PubMed ID: 16543960 [Abstract] [Full Text] [Related]
31. A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model. Bhargava B, Reddy NK, Karthikeyan G, Raju R, Mishra S, Singh S, Waksman R, Virmani R, Somaraju B. Catheter Cardiovasc Interv; 2006 May 08; 67(5):698-702. PubMed ID: 16575925 [Abstract] [Full Text] [Related]
32. Restenosis related to percutaneous coronary intervention has been solved? Kivelä A, Hartikainen J. Ann Med; 2006 May 08; 38(3):173-87. PubMed ID: 16720432 [Abstract] [Full Text] [Related]
33. Local paclitaxel delivery after coronary stenting in an experimental animal model. Dommke C, Haase KK, Süselbeck T, Streitner I, Haghi D, Metz J, Borggrefe M, Herdeg C. Thromb Haemost; 2007 Sep 08; 98(3):674-80. PubMed ID: 17849059 [Abstract] [Full Text] [Related]
38. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention. Newsome LT, Kutcher MA, Royster RL. Anesth Analg; 2008 Aug 08; 107(2):552-69. PubMed ID: 18633035 [Abstract] [Full Text] [Related]
39. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, Mintz GS, Nagata S. J Am Coll Cardiol; 2006 May 16; 47(10):2108-11. PubMed ID: 16697331 [Abstract] [Full Text] [Related]
40. Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents. Bertrand OF, Faurie B, Larose E, Nguyen CM, Gleeton O, Déry JP, Noël B, Proulx G, Roy L, Costerousse O, De Larochellière R, Rodés-Cabau J. J Invasive Cardiol; 2008 Mar 16; 20(3):99-104. PubMed ID: 18316823 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]